Cogentix Medical→Laborie Medical Technologies
Acquisition · Cash · announced Mar 12, 2018
Announced
Mar 12, 2018
Closed
Apr 23, 2019
Economics
Cash()
Pre-deal · pre-deal mark: 2018, year precision · Laborie Medical Technologies press release — Cogentix acquisition, 2019
$3.85/share, ~$214M enterprise value
Target
Cogentix Medical
Pelvic Health · Clinical / therapeutic
HQ Minnetonka, MN · Founded 1997
Urogynecology devices — Urgent PC neuromodulation (percutaneous tibial nerve stimulation for overactive bladder) and PrimeSight cystoscopy with EndoSheath protective barrier
- SEC EDGAR — Cogentix Medical merger filing (Mar 12, 2018)
- Laborie Medical press release (Apr 23, 2019 — completion)
Acquirer
Laborie Medical Technologies
Pelvic Health
HQ Mississauga, Canada
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Urgent PC neuromodulation and PrimeSight cystoscopy expand Laborie's urology/urogynecology portfolio — addresses overactive bladder and stress urinary incontinence
Evidence ladder
Primary (regulatory / filing)
SEC EDGAR — Cogentix Medical merger filing (Mar 12, 2018)
Secondary (press / IR)
Laborie press release (Apr 23, 2019 — completion)
Limitations
- $3.85/share, ~$214M enterprise value
- Pre-deal valuation sourced from: Laborie Medical Technologies press release — Cogentix acquisition, 2019. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Pelvic Health
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Nine Continents Medical | Coloplast | Nov 3, 2020 | same evidence class |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Cogentix Medical (Pelvic Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.